However, an exception was breast cancer, where the group with NT-proBNP levels between 50.4 and 102.9 ng/L had a substantially lower incidence rate compared to the first 2 quartiles (Figure 2B, Supplemental Table 2), a pattern also reflected in female-specific cancers. Here, NPPB is linked to breast cancer.